Southeastern Home Health Services Announces the Launch of Hospice Care Offering

PRESS RELEASE
FOR IMMEDIATE RELEASE 

February 17, 2020 - Southeastern Home Health Services ("Southeastern" or the "Company") announced today that it has added hospice services to its care offering.  The Company has received Medicare certification to provide hospice services and is accredited by the Joint Commission.   The new company will operate as Southeastern Hospice Services, LLC. 

Southeastern's entry into hospice further expands upon the Company's mission to provide skilled home care services to patients with serious, progressive, chronic, life-limiting or life-threatening illnesses. With the addition of hospice services to complement the Company's existing skilled home health and primary and palliative care offerings, Southeastern extends its continuum of care for patients living with a chronic progressive disease, from early diagnosis through the end stages of the illness. George Pinel, CEO, said "We are excited about the addition of hospice services and the ability to further serve our patients."

Founded in 1987, Southeastern operates in 13 offices across Eastern Pennsylvania and Eastern Virginia.  In addition to providing traditional home health and hospice care services, the Company offers a full suite of specialty care services to address patients' needs, including, Palliative, Cardiopulmonary, Infusion, Rehabilitation, Wound Care, Remote Patient Monitoring, Behavioral Health, and Oncology Home Health Care programs. The Company's dedication to the care of its patients and the growth and professional development of its employees serve as the foundation of its success. 

Southeastern was recapitalized in partnership with management by Geneva Glen Capital in 2016.  Southeastern seeks to acquire complementary home care and hospice businesses as part of its strategic growth plan. 

About Geneva Glen Capital, LLC

Geneva Glen Capital is a Chicago-based private equity firm that invests in proven private companies with leading market positions, significant growth potential, and stable cash flows. GGC will consider control buyout transactions as well as minority growth capital investments and targets companies headquartered in the U.S. or Canada with EBITDA between $3 million and $25 million. The firm works closely with management teams to establish and execute on a clearly defined value creation and growth plan. The principals of GGC have extensive private equity experience and a family office-oriented fund structure which provide the ability to be flexible, creative and, if appropriate, long-term investors.  


Jeff Gonyo
Managing Director
(312) 525-8501
jgonyo@genevaglencapital.com

Tom Wuellner
Principal
(312) 525-8503
twuellner@genevaglencapital.com

Adam Schecter
Managing Director
(312) 525-8502
aschecter@genevaglencapital.com

Jeffrey Gonyo